Risk of "silent stroke" in patients older than 60 years: risk assessment and clinical perspectives

Jae-Sung Lim, Hyung-Min Kwon, Jae-Sung Lim, Hyung-Min Kwon

Abstract

With the increasing size of the elderly population and evolving imaging technology, silent brain infarction (SBI) has garnered attention from both the public and the physicians. Over 20% of the elderly exhibit SBI, and the prevalence of SBI increases steadily with age, ie, 30%-40% in those older than 70 years. Well-known cardiovascular risk factors such as hypertension has been identified as a risk factor of SBI (odds ratio [OR] = 3.47) Besides this, blood pressure (BP) reactivity to mental stress, morning BP surges, and orthostatic BP changes have been demonstrated to contribute to the presence of SBI. Further, a metabolic syndrome not only as a whole syndrome (OR =2.18) but also as individual components could have an influence on SBI. Increased C-reactive protein and interleukin-6, coronary artery disease, body mass index, and alcohol consumption have also been associated with SBI. The ORs and possible mechanisms have been discussed in this article. Overt stroke, dementia, depression, and aspiration pneumonia were all associated with SBI. (overt stroke: hazard ratio [HR] =1.9, 95% confidence interval [CI]: 1.2-2.8; dementia: HR =2.26, 95% CI: 1.09-4.70). We also looked into their close relationship with SBI in this review.

Keywords: elderly; risk factors; silent brain infarction; treatment.

Figures

Figure 1
Figure 1
Magnetic resonance imaging from patients with silent brain infarctions and Virchow-Robin spaces: (A) several silent brain infarctions (arrow) in the axial image of the FLAIR sequence; (B–D) numerous Virchow-Robin spaces in the basal ganglia (circle) in the FLAIR axial, T2-weighted axial, and T1-weighted saggital images.
Figure 2
Figure 2
Distribution of SBI. Note: Distribution of the silent brain infarctions is described in the diagram. The number of vertical lines denotes the frequencies (percent) of corresponding lesions. Abbreviations: SBI, silent brain infarction; ref, references.

References

    1. Vermeer SE, Longstreth WT, Jr, Koudstaal PJ. Silent brain infarcts: a systematic review. Lancet Neurol. 2007;6:611–619.
    1. Kobayashi S, Okada K, Koide H, Bokura H, Yamaguchi S. Subcortical silent brain infarction as a risk factor for clinical stroke. Stroke. 1997;28:1932–1939.
    1. Bokura H, Kobayashi S, Yamaguchi S. Distinguishing silent lacunar infarction from enlarged Virchow-Robin spaces: a magnetic resonance imaging and pathological study. J Neurol. 1998;245:116–122.
    1. Wahlund LO, Barkhof F, Fazekas F, et al. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke. 2001;32:1318–1322.
    1. Bernick C, Kuller L, Dulberg C, et al. Silent MRI infarcts and the risk of future stroke: the cardiovascular health study. Neurology. 2001;57:1222–1229.
    1. Vermeer SE, Den Heijer T, Koudstaal PJ, Oudkerk M, Hofman A, Breteler MM. Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke. 2003;34:392–396.
    1. Longstreth WT, Jr, Dulberg C, Manolio TA, et al. Incidence, manifestations, and predictors of brain infarcts defined by serial cranial magnetic resonance imaging in the elderly: the cardiovascular health study. Stroke. 2002;33:2376–2382.
    1. Vermeer SE, Koudstaal PJ, Oudkerk M, Hofman A, Breteler MM. Prevalence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke. 2002;33:21–25.
    1. Matsui T, Arai H, Yuzuriha T, et al. Elevated plasma homocysteine levels and risk of silent brain infarction in elderly people. Stroke. 2001;32:1116–1119.
    1. Shinkawa A, Ueda K, Kiyohara Y, et al. Silent cerebral infarction in a community-based autopsy series in Japan. The Hisayama Study. Stroke. 1995;26:380–385.
    1. Giele JL, Witkamp TD, Mali WP, van der Graaf Y. Silent brain infarcts in patients with manifest vascular disease. Stroke. 2004;35:742–746.
    1. Kwon HM, Kim BJ, Lee SH, Choi SH, Oh BH, Yoon BW. Metabolic syndrome as an independent risk factor of silent brain infarction in healthy people. Stroke. 2006;37:466–470.
    1. Lee SC, Park SJ, Ki HK, et al. Prevalence and risk factors of silent cerebral infarction in apparently normal adults. Hypertension. 2000;36:73–77.
    1. Wada M, Nagasawa H, Iseki C, et al. Cerebral small vessel disease and chronic kidney disease (CKD): results of a cross-sectional study in community-based Japanese elderly. J Neurol Sci. 2008;272:36–42.
    1. Kobayashi M, Hirawa N, Yatsu K, et al. Relationship between silent brain infarction and chronic kidney disease. Nephrol Dial Transplant. 2009;24:201–207.
    1. Kobayashi S, Ikeda T, Moriya H, Ohtake T, Kumagai H. Asymptomatic cerebral lacunae in patients with chronic kidney disease. Am J Kidney Dis. 2004;44:35–41.
    1. Nakatani T, Naganuma T, Uchida J, et al. Silent cerebral infarction in hemodialysis patients. Am J Nephrol. 2003;23:86–90.
    1. Kruit MC, van Buchem MA, Hofman PA, et al. Migraine as a risk factor for subclinical brain lesions. JAMA. 2004;291:427–434.
    1. Uehara T, Tabuchi M, Mori E. Risk factors for silent cerebral infarcts in subcortical white matter and basal ganglia. Stroke. 1999;30:378–382.
    1. Mathiesen EB, Waterloo K, Joakimsen O, Bakke SJ, Jacobsen EA, Bonaa KH. Reduced neuropsychological test performance in asymptomatic carotid stenosis: The Tromso Study. Neurology. 2004;62:695–701.
    1. Hoshi T, Kitagawa K, Yamagami H, Furukado S, Hougaku H, Hori M. Relations of serum high-sensitivity C-reactive protein and interleukin-6 levels with silent brain infarction. Stroke. 2005;36:768–772.
    1. Carey CL, Kramer JH, Josephson SA, et al. Subcortical lacunes are associated with executive dysfunction in cognitively normal elderly. Stroke. 2008;39:397–402.
    1. Das RR, Seshadri S, Beiser AS, et al. Prevalence and correlates of silent cerebral infarcts in the framingham offspring study. Stroke. 2008;39:2929–2935.
    1. Fisher Lacunar infarcts – a review. Cerebrovasc Dis. 1991;1:311–320.
    1. Miao Q, Paloneva T, Tuisku S, et al. Arterioles of the lenticular nucleus in CADASIL. Stroke. 2006;37:2242–2247.
    1. Vermeer SE, Hollander M, van Dijk EJ, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke. 2003;34:1126–1129.
    1. Oh SH, Kim NK, Kim SH, et al. The prevalence and risk factor analysis of silent brain infarction in patients with first-ever ischemic stroke. J Neurol Sci. 2010;293:97–101.
    1. Henry Feugeas MC, de Marco G, Peretti II, Godon-Hardy S, Fredy D, Claeys ES. Age-related cerebral white matter changes and pulse-wave encephalopathy: observations with three-dimensional MRI. Magn Reson Imaging. 2005;23:929–937.
    1. Fernando MS, Simpson JE, Matthews F, et al. White matter lesions in an unselected cohort of the elderly: Molecular pathology suggests origin from chronic hypoperfusion injury. Stroke. 2006;37:1391–1398.
    1. Kruit MC, Launer LJ, van Buchem MA, Terwindt GM, Ferrari MD. MRI findings in migraine. Rev Neurol (Paris) 2005;161:661–665.
    1. Kruit MC, Launer LJ, Ferrari MD, van Buchem MA. Infarcts in the posterior circulation territory in migraine. The population-based MRI CAMERA study. Brain. 2005;128:2068–2077.
    1. Gupta V. Silent or non-clinical infarct-like lesions in the posterior circulation territory in migraine: brain hypoperfusion or hyperperfusion? Brain. 2006;129:E39.
    1. Kotani K, Osaki Y, Sakane N, Adachi S, Ishimaru Y. Risk factors for silent cerebral infarction in the elderly. Arch Med Res. 2004;35:522–524.
    1. Waldstein SR, Siegel EL, Lefkowitz D, et al. Stress-induced blood pressure reactivity and silent cerebrovascular disease. Stroke. 2004;35:1294–1298.
    1. Kario K, Pickering TG, Umeda Y, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation. 2003;107:1401–1406.
    1. Kario K, Eguchi K, Hoshide S, et al. U-curve relationship between orthostatic blood pressure change and silent cerebrovascular disease in elderly hypertensives: orthostatic hypertension as a new cardiovascular risk factor. J Am Coll Cardiol. 2002;40:133–141.
    1. Kario K, Pickering TG. Blood pressure variability in elderly patients. Lancet. 2000;355:1645–1646.
    1. Kuriyama N, Mizuno T, Niwa F, Watanabe Y, Nakagawa M. Autonomic nervous dysfunction during acute cerebral infarction. Neurol Res. Epub 2009 Sep 1.
    1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel III) J Am Med Assoc. 2001;285:2486–2497.
    1. Kwon HM, Kim BJ, Park JH, et al. Significant association of metabolic syndrome with silent brain infarction in elderly people. J Neurol. 2009;256:1825–1831.
    1. Park K, Yasuda N, Toyonaga S, Tsubosaki E, Nakabayashi H, Shimizu K. Significant associations of metabolic syndrome and its components with silent lacunar infarction in middle aged subjects. J Neurol Neurosurg Psychiatry. 2008;79:719–721.
    1. Gazdzinski S, Kornak J, Weiner MW, Meyerhoff DJ. Body mass index and magnetic resonance markers of brain integrity in adults. Ann Neurol. 2008;63:652–657.
    1. Lusis AJ, Attie AD, Reue K. Metabolic syndrome: From epidemiology to systems biology. Nat Rev Genet. 2008;9:819–830.
    1. Kawamoto R, Tomita H, Oka Y, Kodama A. Metabolic syndrome as a predictor of ischemic stroke in elderly persons. Intern Med. 2005;44:922–927.
    1. van Dijk EJ, Prins ND, Vermeer SE, et al. C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study. Circulation. 2005;112:900–905.
    1. Fassbender K, Bertsch T, Mielke O, Muhlhauser F, Hennerici M. Adhesion molecules in cerebrovascular diseases. Evidence for an inflammatory endothelial activation in cerebral large- and small-vessel disease. Stroke. 1999;30:1647–1650.
    1. Hassan A, Hunt BJ, O’Sullivan M, et al. Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. Brain. 2003;126:424–432.
    1. Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: An integrated view. Trends Neurosci. 1999;22:391–397.
    1. Vermeer SE, van Dijk EJ, Koudstaal PJ, et al. Homocysteine, silent brain infarcts, and white matter lesions: the Rotterdam Scan Study. Ann Neurol. 2002;51:285–289.
    1. Kim NK, Choi BO, Jung WS, Choi YJ, Choi KG. Hyperhomocysteinemia as an independent risk factor for silent brain infarction. Neurology. 2003;61:1595–1599.
    1. Stein JH, McBride PE. Hyperhomocysteinemia and atherosclerotic vascular disease: pathophysiology, screening, and treatment off. Arch Intern Med. 1998;158:1301–1306.
    1. Uekita K, Hasebe N, Funayama N, et al. Cervical and intracranial atherosclerosis and silent brain infarction in Japanese patients with coronary artery disease. Cerebrovasc Dis. 2003;16:61–68.
    1. Hoshide S, Kario K, Mitsuhashi T, et al. Different patterns of silent cerebral infarct in patients with coronary artery disease or hypertension. Am J Hypertens. 2001;14:509–515.
    1. Sato H, Koretsune Y, Fukunami M, et al. Aspirin attenuates the incidence of silent brain lesions in patients with nonvalvular atrial fibrillation. Circ J. 2004;68:410–416.
    1. Minamino T, Kitakaze M, Sato H, et al. Plasma levels of nitrite/nitrate and platelet cGMp levels are decreased in patients with atrial fibrillation. Arterioscler Thromb Vasc Biol. 1997;17:3191–3195.
    1. Minamino T, Kitakaze M, Sanada S, et al. Increased expression of P-selectin on platelets is a risk factor for silent cerebral infarction in patients with atrial fibrillation: role of nitric oxide. Circulation. 1998;98:1721–1727.
    1. Noris M, Morigi M, Donadelli R, et al. Nitric oxide synthesis by cultured endothelial cells is modulated by flow conditions. Circ Res. 1995;76:536–543.
    1. Topper JN, Cai J, Falb D, Gimbrone MA., Jr Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress. Proc Natl Acad Sci U S A. 1996;93:10417–10422.
    1. Notsu Y, Nabika T, Park HY, Masuda J, Kobayashi S. Evaluation of genetic risk factors for silent brain infarction. Stroke. 1999;30:1881–1886.
    1. Markus HS, Barley J, Lunt R, et al. Angiotensin-converting enzyme gene deletion polymorphism. A new risk factor for lacunar stroke but not carotid atheroma. Stroke. 1995;26:1329–1333.
    1. Song J, Kim OJ, Kim HS, et al. Endothelial nitric oxide synthase gene polymorphisms and the risk of silent brain infarction. Int J Mol Med. 2010;25:819–823.
    1. Elbaz A, Poirier O, Moulin T, Chedru F, Cambien F, Amarenco P. Association between the Glu298Asp polymorphism in the endothelial constitutive nitric oxide synthase gene and brain infarction. The GENIC investigators. Stroke. 2000;31:1634–1639.
    1. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest. 1989;83:1774–1777.
    1. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A. 1991;88:4651–4655.
    1. Wolf A, Zalpour C, Theilmeier G, et al. Dietary l-arginine supplementation normalizes platelet aggregation in hypercholesterolemic humans. J Am Coll Cardiol. 1997;29:479–485.
    1. Serizawa M, Nabika T, Ochiai Y, et al. Association between PRKCH gene polymorphisms and subcortical silent brain infarction. Atherosclerosis. 2008;199:340–345.
    1. van Rijn MJ, Bos MJ, Yazdanpanah M, et al. Alpha-adducin polymorphism, atherosclerosis, and cardiovascular and cerebrovascular risk. Stroke. 2006;37:2930–2934.
    1. Kimberly WT, Gilson A, Rost NS, et al. Silent ischemic infarcts are associated with hemorrhage burden in cerebral amyloid angiopathy. Neurology. 2009;72:1230–1235.
    1. Avdibegovic E, Becirovic E, Selimbasic Z, Hasanovic M, Sinanovic O. Cerebral cortical atrophy and silent brain infarcts in psychiatric patients. Psychiatr Danub. 2007;19:49–55.
    1. Handa K, Sasaki J, Saku K, Kono S, Arakawa K. Alcohol consumption, serum lipids and severity of angiographically determined coronary artery disease. Am J Cardiol. 1990;65:287–289.
    1. Rimm EB, Giovannucci EL, Willett WC, et al. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet. 1991;338:464–468.
    1. Eguchi K, Kario K, Hoshide S, et al. Smoking is associated with silent cerebrovascular disease in a high-risk Japanese community-dwelling population. Hypertens Res. 2004;27:747–754.
    1. Yamashita K, Kobayashi S, Yamaguchi S, Koide H. Cigarette smoking and silent brain infarction in normal adults. Intern Med. 1996;35:704–706.
    1. Howard G, Wagenknecht LE, Cai J, Cooper L, Kraut MA, Toole JF. Cigarette smoking and other risk factors for silent cerebral infarction in the general population. Stroke. 1998;29:913–917.
    1. Igase M, Tabara Y, Igase K, et al. Asymptomatic cerebral microbleeds seen in healthy subjects have a strong association with asymptomatic lacunar infarction. Circ J. 2009;73:530–533.
    1. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003;348:1215–1222.
    1. Fujikawa T, Yamawaki S, Touhouda Y. Incidence of silent cerebral infarction in patients with major depression. Stroke. 1993;24:1631–1634.
    1. Nakagawa T, Sekizawa K, Nakajoh K, Tanji H, Arai H, Sasaki H. Silent cerebral infarction: a potential risk for pneumonia in the elderly. J Intern Med. 2000;247:255–259.
    1. Wada H, Nakajoh K, Satoh-Nakagawa T, et al. Risk factors of aspiration pneumonia in Alzheimer‘s disease patients. Gerontology. 2001;47:271–276.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する